000403 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the research, development, production and marketing of blood products. It specializes in the human serum albumin, intravenous human immunoglobulin, human immunoglobulin, human hepatitis B immunoglobulin, tetanus human immunoglobulin, human coagulation factor VIII, human prothrombin complex and rabies immunoglobulin. The company was founded on December 28, 1993 and is headquartered in Zhanjiang, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
000403 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company